- Trials with a EudraCT protocol (194)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (1)
194 result(s) found for: Erythrocyte Sedimentation Rate.
Displaying page 1 of 10.
EudraCT Number: 2007-003479-37 | Sponsor Protocol Number: CER 06-167 | Start Date*: 2008-03-26 |
Sponsor Name:University Hospital of Geneva [...] | ||
Full Title: Efficacy of Methotrexate on Chronic Chondrocalcinosis | ||
Medical condition: Chronic Chondrocalcinosis | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: IE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2007-004269-16 | Sponsor Protocol Number: IGFI-1 | Start Date*: 2008-02-28 |
Sponsor Name:Queen Mary, University of London | ||
Full Title: Pharmacokinetic studies of recombinant human insulin-like growth factor I (rhIGF-I) in children with Crohn’s disease-induced growth retardation. | ||
Medical condition: Growth failure in children with Crohn's disease | ||
Disease: | ||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2006-000514-21 | Sponsor Protocol Number: AG-PH3 | Start Date*: 2007-01-02 |
Sponsor Name:CIS bio International | ||
Full Title: Multicenter, randomized, open-label, clinical study on the agreement of Scintimun® Granulocyte and labeled 99mTc-White Blood Cells in diagnosing infection/inflammation by immunoscintigraphy in peri... | ||
Medical condition: Patients with suspected or documented osteomyelitis in the peripheral skeleton including patients with loosening of joint prosthesis or diabetic foot. At least one of following signs or symptoms is... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Completed) HU (Completed) DE (Completed) CZ (Completed) | ||
Trial results: View results |
EudraCT Number: 2019-004178-24 | Sponsor Protocol Number: 1704 | Start Date*: 2020-06-13 | ||||||||||||||||
Sponsor Name:Amphia | ||||||||||||||||||
Full Title: Defining long-term macrolide maintenance therapy in COPD: a single center randomized controlled trial: | ||||||||||||||||||
Medical condition: Chronic obstructive pulmonary disease COPD | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: NL (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-001586-87 | Sponsor Protocol Number: RSLV-132-04 | Start Date*: 2016-09-29 |
Sponsor Name:Resolve Therapeutics, LLC | ||
Full Title: A Phase 2, Double Blind, Placebo Controlled Study of RSLV-132 in Subjects with Primary Sjogren’s Syndrome | ||
Medical condition: Primary Sjogrens Syndrome | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2008-006837-28 | Sponsor Protocol Number: PML_DOC_0804 | Start Date*: 2008-12-08 |
Sponsor Name:University Hospital Antwerp; Department Respiratory Medicine | ||
Full Title: Double blind, randomized, placebo-controlled, two-way crossover, pilot study to assess the effect of high dose N-acetylcysteine on small airways and on inflammation and oxidative stress in COPD pat... | ||
Medical condition: Chronic Obstructive Pulmonary Disease | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: BE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2007-003946-13 | Sponsor Protocol Number: PML_NAC_01 | Start Date*: 2007-09-05 |
Sponsor Name:University Hospital Antwerp; Department Respiratory Medicine | ||
Full Title: Double blind, randomized, placebo-controlled, two-way crossover, pilot study to assess the effect of high dose N acetylcysteine on small airways and on inflammation and oxidative stress in COPD pat... | ||
Medical condition: Chronic Obstructive Pulmonary Disease | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: BE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2017-001429-41 | Sponsor Protocol Number: ML39568 | Start Date*: 2017-12-20 | |||||||||||
Sponsor Name:AZIENDA OSPEDALIERO-UNIVERSITARIA DI PARMA | |||||||||||||
Full Title: “TOCIlizumab for difficult-to-treat RETroperitoneal fibrosis. TOCIRET Trial” | |||||||||||||
Medical condition: idiopathic retroperitoneal fibrosis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-000233-73 | Sponsor Protocol Number: HCQvJan11 | Start Date*: 2016-01-05 |
Sponsor Name:Helsinki University Central Hospital | ||
Full Title: HYDROXYCHLOROQUINE IN ACUTE CORONARY SYNDROME: PREVENTION OF RECURRENT CARDIOVASCULAR EVENTS | ||
Medical condition: Cardiovascular disease | ||
Disease: | ||
Population Age: Elderly | Gender: Male, Female | |
Trial protocol: FI (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2009-014824-40 | Sponsor Protocol Number: ART621-290 | Start Date*: 2009-11-03 |
Sponsor Name:Arana Therapeutics Ltd | ||
Full Title: An open label follow on study to evaluate the long-term safety, tolerability and efficacy of ART621 following fortnightly administration for 48 weeks in patients with rheumatoid arthritis concomita... | ||
Medical condition: Rheumatoid arthritis | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: CZ (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2014-000350-11 | Sponsor Protocol Number: 2032/MUL | Start Date*: 2014-05-28 | |||||||||||||||||||||
Sponsor Name:Multiplex Pharma Holdings LLC | |||||||||||||||||||||||
Full Title: An open label, randomized study to investigate the safety of weekly pentosan polysulfate injections in adult patients with Mucopolysaccharidosis Type I receiving enzyme replacement therapy. | |||||||||||||||||||||||
Medical condition: Mucopolysaccharidosis type I (alpha-L-Iduronidase deficiency) | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: DE (Completed) | |||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2014-000047-33 | Sponsor Protocol Number: VitD-EX1.0 | Start Date*: 2014-03-20 |
Sponsor Name:VU University Medical Centre | ||
Full Title: The effect of high-resistance muscle strength training and vitamin D supplementation in persons with knee osteoarthritis | ||
Medical condition: knee osteoarthritis vitamin D deficiency | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2014-004103-73 | Sponsor Protocol Number: 0881A1-207 | Start Date*: 2015-03-12 |
Sponsor Name:Wyeth Kabushiki Kaisha (Wyeth K.K.) | ||
Full Title: A long-term, open-label study of TNR-001 in Japanese Juvenile Idiopathic Arthritis Subjects. | ||
Medical condition: Juvenile idiopathic arthritis (JIA) | ||
Disease: | ||
Population Age: Children, Adolescents, Under 18, Adults | Gender: Male, Female | |
Trial protocol: Outside EU/EEA | ||
Trial results: View results |
EudraCT Number: 2015-002156-27 | Sponsor Protocol Number: 1356/2015 | Start Date*: Information not available in EudraCT |
Sponsor Name:Medical University of Vienna | ||
Full Title: Prospective controlled study of reduced-dose Rituximab in rheumatoid arthritis patients in low disease activity and remission – the REDOREM study | ||
Medical condition: rheumatoid arthritis | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: AT (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2005-004582-41 | Sponsor Protocol Number: RTX/LFU rheumatoid arthritis. | Start Date*: 2006-03-24 |
Sponsor Name:University of Leeds | ||
Full Title: Safety and efficacy of combination treatment with rituximab and leflunomide in patients with active rheumatoid arthritis | ||
Medical condition: Active Rheumatoid Arthritis | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2020-001019-26 | Sponsor Protocol Number: 202000167 | Start Date*: 2021-02-26 |
Sponsor Name:University Medical Center Groningen, Department of Rheumatology and Clinical Immunology | ||
Full Title: [18F]fluor-PEG-folate PET/CT imaging in Giant Cell Arteritis: a pilot study. | ||
Medical condition: giant cell arteritis | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2014-004381-24 | Sponsor Protocol Number: C87035 | Start Date*: 2015-03-02 | |||||||||||
Sponsor Name:UCB Celltech | |||||||||||||
Full Title: A Phase 2, Open-label, Multicenter Study to Assess the Safety and Efficacy of Certolizumab Pegol in Children and Adolescents With Active Crohn's Disease (NURTURE Study) | |||||||||||||
Medical condition: Crohn’s Disease | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: Outside EU/EEA | |||||||||||||
Trial results: View results |
EudraCT Number: 2004-000482-35 | Sponsor Protocol Number: ARA102198 | Start Date*: 2004-10-11 |
Sponsor Name:GlaxoSmithKline Research & Development Ltd. | ||
Full Title: A randomised, double-blind, placebo-controlled, parallel group study to investigate the anti-inflammatory and metabolic effects of rosiglitazone XR, 8mg once daily, in subjects with rheumatoid arth... | ||
Medical condition: Rheumatoid Arthritis | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) LT (Completed) | ||
Trial results: View results |
EudraCT Number: 2019-000660-25 | Sponsor Protocol Number: CT-P17_3.2 | Start Date*: 2019-07-09 | |||||||||||
Sponsor Name:CELLTRION, Inc. | |||||||||||||
Full Title: A Phase III, Open-label, Single-arm, Multiple-dose Study to Evaluate Usability of Subcutaneous Auto-injector of CT-P17 in Patients with Moderate to Severe Active Rheumatoid Arthritis | |||||||||||||
Medical condition: Moderate to Severe Active Rheumatoid Arthritis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: PL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-001625-10 | Sponsor Protocol Number: 0881X1-4437 | Start Date*: 2008-06-16 | |||||||||||
Sponsor Name:Wyeth Pharmaceuticals France | |||||||||||||
Full Title: An Open-Label, Randomized Study To Evaluate The Radiographic Efficacy And Safety Of Enbrel™ (Etanercept) Added To Methotrexate In Comparison With Usual Treatment In Subjects With Moderate Rheumatoi... | |||||||||||||
Medical condition: RHEUMATOID ARTHRITIS | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: HU (Prematurely Ended) ES (Completed) GB (Prematurely Ended) DE (Prematurely Ended) FR (Completed) CZ (Prematurely Ended) AT (Prematurely Ended) PL (Prematurely Ended) DK (Completed) IE (Prematurely Ended) GR (Prematurely Ended) IT (Prematurely Ended) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.